ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12247 recruiting trials
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
👨⚕️ Daniel R Richardson, MD, MA, MSc, UNC Lineberger Comprehensive Cancer Center📍 1 site📅 Started Jun 2024View details ↗
Connective Tissue Massage in Scleroderma
RecruitingNCT07224750 ↗
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
👨⚕️ Jéremy CAMPILLO, PharmD PhD, Institut de Recherche pour le Développement (IRD)📍 2 sites📅 Started Jun 2024View details ↗
A Mobile Gaming App to Improve Adherence to PrEP
SBRT in HCC With Oligoprogression on First-line Immunotherapy
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas
Ozone Therapy in Patients With Carpal Tunnel Syndrome
Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene
👨⚕️ Alice S Mims, Ohio State University Comprehensive Cancer Center LAO📍 22 sites📅 Started Jun 2024View details ↗
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination
👨⚕️ Tienan Zhu, M.D., Peking Union Medical College Hospital📍 1 site📅 Started Jun 2024View details ↗
The Peripheral Blood Multi-Omics Study on Sleep Loss
RecruitingNCT06323876 ↗
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
Enrolling by InvitationNCT06475196 ↗
Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC
RecruitingNCT06376786 ↗
Italian iTTP Registry
👨⚕️ Flora Peyvandi, MD, PhD, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy📍 1 site📅 Started Jun 2024View details ↗
Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RecruitingNCT06512714 ↗
Mycetoma Retrospective Data Collection
Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →